JP2023535405A5 - - Google Patents
Info
- Publication number
- JP2023535405A5 JP2023535405A5 JP2023504251A JP2023504251A JP2023535405A5 JP 2023535405 A5 JP2023535405 A5 JP 2023535405A5 JP 2023504251 A JP2023504251 A JP 2023504251A JP 2023504251 A JP2023504251 A JP 2023504251A JP 2023535405 A5 JP2023535405 A5 JP 2023535405A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- administration
- cov
- cancer
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063055165P | 2020-07-22 | 2020-07-22 | |
| US63/055,165 | 2020-07-22 | ||
| US202063060503P | 2020-08-03 | 2020-08-03 | |
| US63/060,503 | 2020-08-03 | ||
| US202063108980P | 2020-11-03 | 2020-11-03 | |
| US63/108,980 | 2020-11-03 | ||
| PCT/US2021/042684 WO2022020542A1 (en) | 2020-07-22 | 2021-07-22 | Treatment and prevention of conditions associated with respiratory diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535405A JP2023535405A (ja) | 2023-08-17 |
| JP2023535405A5 true JP2023535405A5 (cg-RX-API-DMAC10.html) | 2025-04-17 |
Family
ID=79729865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504251A Pending JP2023535405A (ja) | 2020-07-22 | 2021-07-22 | 呼吸器疾患に関連する状態の処置および防止 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230270845A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4185272A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023535405A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3186799A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022020542A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025504814A (ja) * | 2022-01-21 | 2025-02-19 | ユニバーシティー オブ ヒューストン システム | 呼吸器疾患のための経鼻ワクチンおよび治療剤 |
| CN114712304B (zh) * | 2022-04-18 | 2024-03-12 | 深圳大学 | 海藻酸钠基复合水凝胶的制备方法 |
| WO2025194158A1 (en) * | 2024-03-15 | 2025-09-18 | University Of Houston System | Mucosal vaccines against respiratory syncytial virus |
| WO2025199149A1 (en) * | 2024-03-18 | 2025-09-25 | Cour Pharmaceuticals Development Company Inc. | Sting agonism for antigen specific tolerance |
| CN120459057B (zh) * | 2025-06-06 | 2026-04-14 | 上海大学 | 一种单核细胞搭载型产氧脂质体及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8080642B2 (en) * | 2003-05-16 | 2011-12-20 | Vical Incorporated | Severe acute respiratory syndrome DNA compositions and methods of use |
| KR102483033B1 (ko) * | 2016-05-16 | 2022-12-30 | 액세스 투 어드밴스드 헬스 인스티튜트 | 페길화된 리포솜 및 이의 용도 |
| EP3471778A4 (en) * | 2016-06-20 | 2020-02-19 | The Regents of The University of Michigan | COMPOSITIONS AND METHOD FOR DELIVERING BIOMACROMOLECOLIC ACTIVE SUBSTANCES |
| KR101982710B1 (ko) * | 2017-03-17 | 2019-05-28 | 주식회사 큐라티스 | 스팅 작용자를 포함하는 면역항원보강제 및 백신 조성물 |
| TW202003032A (zh) * | 2018-03-23 | 2020-01-16 | 美商科迪亞克生物科學公司 | 包含s t i n g 促效劑之胞外囊泡 |
-
2021
- 2021-07-22 JP JP2023504251A patent/JP2023535405A/ja active Pending
- 2021-07-22 US US18/017,659 patent/US20230270845A1/en active Pending
- 2021-07-22 CA CA3186799A patent/CA3186799A1/en active Pending
- 2021-07-22 EP EP21847219.9A patent/EP4185272A4/en active Pending
- 2021-07-22 WO PCT/US2021/042684 patent/WO2022020542A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110520438A (zh) | 溶瘤病毒疗法 | |
| JP7672657B2 (ja) | 核酸脂質粒子ワクチン | |
| CN106459998A (zh) | 预防或治疗慢性乙型肝炎病毒(hbv)感染的基于病毒样囊泡(vlv)的疫苗 | |
| CN111154806A (zh) | 一种嵌合外源超级细胞因子的溶瘤病毒载体系统及其在药物中的应用 | |
| AU2022422532A1 (en) | Immunostimulatory mrna compositions and uses thereof | |
| CN116200394A (zh) | CpG寡聚脱氧核苷酸及其应用 | |
| AU2023307031A1 (en) | Recombinant oncolytic virus and use thereof | |
| CN117298264A (zh) | 基于流感病毒ha蛋白和新冠病毒s蛋白的组合物和疫苗 | |
| Zhang et al. | mRNA-encoded mutant HPV16/18 vaccines promote specific T-cell responses and synergize with anti-PD-1 checkpoint blockade in mediating therapeutic tumor regression in mice | |
| CN116568309B (zh) | 一种用于预防或治疗慢性乙型肝炎的药物组合制剂及其用途以及组合制剂试剂盒 | |
| CN105797147B (zh) | Cxcl13 dna疫苗及其应用 | |
| CN115804853A (zh) | 包含rna分子的组合物及其在制备瘤内注射剂中的用途 | |
| CN104768575B (zh) | 含有vegf特异性表位和/或血管生成素‑2特异性表位的dna疫苗 | |
| KR102673991B1 (ko) | 경비 b형 간염 백신 조성물 및 그 제조방법 | |
| EP3713600B1 (en) | Synthetic hemagglutinin as universal vaccine against infection by type b influenza viruses (ibv) | |
| CN106075432A (zh) | 皮卡钙联合佐剂及含有皮卡钙联合佐剂的疫苗 | |
| CN110139875B (zh) | Col14a1衍生的肿瘤抗原多肽及其应用 | |
| JP2023549675A5 (cg-RX-API-DMAC10.html) | ||
| Nam et al. | Modulation of immune response induced by co-administration of DNA vaccine encoding HBV surface antigen and HCV envelope antigen in BALB/c mice | |
| JPWO2010109706A1 (ja) | 分子標的薬に対する感受性が低下している癌の治療薬および分子標的薬に対する感受性を増強する医薬組成物 | |
| CN116621966B (zh) | 治疗性核酸分子、混合物、药物及在治疗实体瘤中的应用 | |
| US20220370581A1 (en) | Vaccine and method for treating cancer | |
| CA3141323C (en) | Recombinant interleukin 12 construct and uses thereof | |
| US20230390384A1 (en) | Recombinant covid-19 vaccine composition comprising lipopeptide and poly (i:c) adjuvant, and use thereof | |
| KR101293363B1 (ko) | 인터페론 수용체 유전자를 포함하는 조류독감 예방용 조성물 |